Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

休市中 04-26 16:00:00 EDT

6.87

+0.05

+0.73%

盘后6.61

-0.26-3.78%

19:55 EDT

最高7.14	最低6.52	成交量97.83万
今开6.83	昨收6.82	日振幅9.09%
总市值4.84亿	流通市值2.19亿	总股本7,047万
成交额663.96万	换手率3.07%	流通股本3,191万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":6.87,"timestamp":1714161600000,"preClose":6.82,"halted":0,"volume":978276,"hourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.87,"latestTime":"19:55 EDT","volume":4195,"amount":28816.6414,"timestamp":1714175713423},"delay":0,"floatShares":31913580,"shares":70467620,"eps":-2.397279,"marketStatus":"休市中","marketStatusCode":7,"change":0.05,"latestTime":"04-26 16:00:00 EDT","open":6.83,"high":7.14,"low":6.52,"amount":6639624.267353999,"amplitude":0.090909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.397279,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":1594353600000,"adjPreClose":6.82,"preHourTrading":{"tag":"盘前","latestPrice":6.7,"preClose":6.82,"latestTime":"09:04 EDT","volume":2040,"amount":13788.00096,"timestamp":1714136683418},"postHourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.87,"latestTime":"19:55 EDT","volume":4195,"amount":28816.6414,"timestamp":1714175713423},"volumeRatio":1.0885940682268709},"requestUrl":"/m/hq/s/NKTX/","defaultTab":"news","newsList":[{"id":"2430281976","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.02%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281976","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430281976?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:48","pubTimestamp":1714052903,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时48分，Nkarta, Inc.股票出现异动，股价快速下跌5.02%。截至发稿，该股报6.81美元/股，成交量16.5528万股，换手率0.24%，振幅2.65%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521482487e83b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521482487e83b6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113883","title":"Nkarta, Inc.盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113883","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113883?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:03","pubTimestamp":1713881018,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时03分，Nkarta, Inc.股票出现波动，股价快速上涨5.14%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Palisade Bio, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Azitra Inc涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为1943.10%、167.66%、27.09%，振幅较大的相关个股有Palisade Bio, Inc.、Moolec Science Sa C/Wts 、Immunitybio, Inc.，振幅分别为32.86%、26.18%、25.10%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232203387a54ef83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232203387a54ef83&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428866544","title":"Nkarta, Inc.盘中异动 临近午盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428866544","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428866544?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:31","pubTimestamp":1713540716,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时31分，Nkarta, Inc.股票出现异动，股价急速下跌5.01%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。该公司致力于利用 NK 细胞的天然强大力量来识别和杀死异常细胞，并招募适应性免疫效应器以产生特异性和持久的反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419233156861e77cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419233156861e77cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428592708","title":"Nkarta, Inc.盘中异动 早盘急速下挫5.03%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428592708","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428592708?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:42","pubTimestamp":1713447734,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时42分，Nkarta, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报7.47美元/股，成交量2.9553万股，换手率0.04%，振幅4.07%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821421487e81bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821421487e81bd1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427182029","title":"Nkarta, Inc.盘中异动 早盘快速下挫5.84%报8.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427182029","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427182029?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:30","pubTimestamp":1713274259,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时30分，Nkarta, Inc.股票出现波动，股价快速下挫5.84%。截至发稿，该股报8.22美元/股，成交量7522股，换手率0.01%，振幅0.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130597920f366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130597920f366&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426260805","title":"Nkarta, Inc.盘中异动 快速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426260805","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426260805?lang=zh_cn&edition=full","pubTime":"2024-04-12 00:20","pubTimestamp":1712852423,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日00时20分，Nkarta, Inc.股票出现异动，股价大幅上涨5.21%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。该信息摘要如下：Needham：重申Nkarta评级，由买入调整至买入评级, 目标价15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412002024791ff565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412002024791ff565&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494909","title":"Nkarta, Inc.盘中异动 急速跳水5.03%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494909?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:31","pubTimestamp":1712755904,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时31分，Nkarta, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报8.31美元/股，成交量2.6614万股，换手率0.04%，振幅2.06%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。该信息摘要如下：Needham：重申Nkarta评级，由买入调整至买入评级, 目标价15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021314587e7f483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021314587e7f483&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426467158","title":"Needham：重申Nkarta(NKTX.US)评级，由买入调整至买入评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426467158","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426467158?lang=zh_cn&edition=full","pubTime":"2024-04-10 19:46","pubTimestamp":1712749563,"startTime":"0","endTime":"0","summary":"Needham：重申Nkarta(NKTX.US)评级，由买入调整至买入评级, 目标价15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101946078760de35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101946078760de35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424738826","title":"Nkarta, Inc.盘中异动 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424738826","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424738826?lang=zh_cn&edition=full","pubTime":"2024-04-03 23:54","pubTimestamp":1712159654,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日23时54分，Nkarta, Inc.股票出现异动，股价急速下挫5.06%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为491.74%、446.87%、68.61%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进，振幅分别为97.51%、58.48%、44.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403235415861e35a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403235415861e35a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424704332","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.73%报10.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424704332","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424704332?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:30","pubTimestamp":1712064657,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时30分，Nkarta, Inc.股票出现异动，股价大幅跳水5.73%。截至发稿，该股报10.20美元/股，成交量2.1514万股，换手率0.03%，振幅0.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213057791e7ca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402213057791e7ca0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422291894","title":"Nkarta, Inc.盘中异动 大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422291894","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422291894?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:47","pubTimestamp":1711547258,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时47分，Nkarta, Inc.股票出现波动，股价急速拉升5.07%。截至发稿，该股报10.37美元/股，成交量17.0357万股，换手率0.24%，振幅5.42%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327214738791d4bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327214738791d4bf1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422613134","title":"Nkarta, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422613134","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422613134?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:32","pubTimestamp":1711459941,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时32分，Nkarta, Inc.股票出现异动，股价快速拉升5.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大，Abvc Biopharma, Inc.、Xtl生物制药、Stoke Therapeutics, Inc.较为活跃，换手率分别为99.46%、11.05%、10.02%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Molecular Templates, Inc.、Sellas Life Sciences Group, Inc.，振幅分别为24.77%、14.64%、9.62%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3429&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422195548","title":"Nkarta, Inc.盘中异动 股价大涨25.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422195548","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422195548?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373503,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Nkarta, Inc.股票出现异动，股价急速上涨25.29%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为810.36%、47.09%、31.06%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Ocugen, Inc.，振幅分别为21.97%、15.26%、8.53%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521314387b3418e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521314387b3418e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421845483","title":"BUZZ-Nkarta公司放弃血癌疗法开发后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2421845483","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421845483?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:34","pubTimestamp":1711121640,"startTime":"0","endTime":"0","summary":"    3月22日 - ** 疗法开发商Nkarta公司  股价下跌22.1%，至10.11美元 ** 该公司周四晚些时候公布的全年净亏损为1.175亿美元，去年同期为1.138亿美元* * 在一项早期研究显示部分患者的反应率明显降低后，该公司 表示已将其治疗一种血癌的疗法-- NKX101--置于 次要 地位     ** 公司将专注于推进自身免疫性疾病的治疗 ** 瑞穗证券将该公司的目标价从31美元下调至25美元，股票评级为 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421819973","title":"Nkarta, Inc.盘中异动 股价大跌26.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421819973","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421819973?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:31","pubTimestamp":1711114281,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时31分，Nkarta, Inc.股票出现异动，股价大幅下挫26.81%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Gt Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Okyo Pharma Ltd Com Npv 、Revelation Biosciences, Inc.、Nutriband Inc.较为活跃，换手率分别为4.70%、3.52%、3.34%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Xtl生物制药、Nkarta, Inc.，振幅分别为32.68%、10.74%、9.40%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312187a7af9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312187a7af9f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421466320","title":"Nkarta, Inc.盘中异动 股价大涨5.32%报13.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421466320","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421466320?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:37","pubTimestamp":1711028235,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时37分，Nkarta, Inc.股票出现异动，股价急速拉升5.32%。截至发稿，该股报13.47美元/股，成交量4.1791万股，换手率0.09%，振幅2.42%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213716861e0181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213716861e0181&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420272401","title":"Nkarta, Inc.盘中异动 急速拉升5.00%报11.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420272401","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420272401?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:11","pubTimestamp":1710864677,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时11分，Nkarta, Inc.股票出现波动，股价大幅上涨5.00%。截至发稿，该股报11.97美元/股，成交量17.7199万股，换手率0.36%，振幅8.07%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032000111787e7a1c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032000111787e7a1c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420479471","title":"Nkarta, Inc.盘中异动 股价大跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420479471","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420479471?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:32","pubTimestamp":1710768724,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时32分，Nkarta, Inc.股票出现异动，股价大幅下挫5.75%。截至发稿，该股报11.47美元/股，成交量2.8716万股，换手率0.06%，振幅6.58%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213204791b34d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213204791b34d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419974229","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974229","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419974229?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:31","pubTimestamp":1710509498,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时31分，Nkarta, Inc.股票出现波动，股价大幅上涨5.45%。截至发稿，该股报12.00美元/股，成交量5.8147万股，换手率0.12%，振幅4.48%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152131388b37b753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152131388b37b753&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419236607","title":"Nkarta, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419236607","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419236607?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:50","pubTimestamp":1710424252,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时50分，Nkarta, Inc.股票出现异动，股价急速跳水5.12%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为200.94%、135.02%、65.33%，振幅较大的相关个股有知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.，振幅分别为65.13%、40.32%、38.38%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发用于治疗癌症的工程化自然杀伤  细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215052861de3df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215052861de3df&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.0576},{"period":"1month","weight":-0.3802},{"period":"3month","weight":-0.2508},{"period":"6month","weight":2.3512},{"period":"1year","weight":0.4136},{"period":"ytd","weight":0.0409}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司，致力于开发工程化的自然杀伤（NK）细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞，并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082272},{"month":4,"riseRate":0.5,"avgChangeRate":0.15459},{"month":5,"riseRate":0,"avgChangeRate":-0.173203},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.123587},{"month":7,"riseRate":1,"avgChangeRate":0.048154},{"month":8,"riseRate":0.5,"avgChangeRate":-0.052154},{"month":9,"riseRate":0.25,"avgChangeRate":-0.049361},{"month":10,"riseRate":0.25,"avgChangeRate":-0.015611},{"month":11,"riseRate":0.75,"avgChangeRate":0.036387},{"month":12,"riseRate":0.5,"avgChangeRate":0.50486}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}